-
Leeds rally for 4-2 friendly win over Liverpool
-
Four Al-Fayed survivors told they were trafficking victims
-
Trump says US support for Japanese yen a 'signal of friendship'
-
Ariana Grande withdraws from London musical, seeks to 'step back'
-
Thorbjornsen earns maiden PGA win at Rocket Classic
-
Sudan army drone attack on Darfur court kills 35
-
Greaves steadies West Indies in second Test against Pakistan
-
At least 72 died in Spain's Ceuta migrant rush, Spain says
-
Zverev says sanctions won't solve problem of bloated Masters events
-
Russian teen Liutova wins WTA Memphis title
-
Brazil's Lula, 80, says 'in great shape' as he launches fourth term bid
-
Zverev remains wary of 12-day Masters events
-
Barco joins Chelsea rebuild from Strasbourg
-
Wimbledon champ Noskova ready for 'new opportunity'
-
Commonwealth Games faces uncertain future ahead of centenary edition
-
Japan's Kuwaki wins women's British Open to clinch first major title
-
Moroccans gather at Ceuta border, desperate for news of loved ones
-
Sabalenka aims to bounce back in Toronto after Wimbledon disappointment
-
Finucane seals fourth cycling gold on final day of Commonwealth Games
-
Iran says close to Hormuz deal with Oman, after US suspends attack plan
-
At Nepal school, outpouring of grief for climber Nirmal Purja
-
'Spider-Man' soars to huge $355 million opening in North America
-
Tourists slowly return to French bay opposite huge wildfire
-
Handbag tosses and high-heeled sprints: Amsterdam celebrates Drag Olympics
-
Helicopter crew killed in Greece fires
-
Trump's on-again-off-again war against Iran: in his own words
-
Wiebes takes dominant second win at Tour de France Femmes
-
Dodgers land Tigers pitching ace Skubal in MLB trade deadline blockbuster
-
Suicide attack kills 13 during protest in northern Pakistan: police
-
Infantino struggling to survive, says former IOC marketing chief
-
Helicopters collide in Greece as fires spread
-
OPEC+ boosts September production by 188,000 barrels/day
-
Power returns to Cuba's west after grid failure
-
Rescuers recover climber Nirmal Purja's body after avalanche disaster
-
At least 72 died in Spain's Ceuta migrant rush
-
Fire toll mounts in Greece as blazes spread
-
South Korea records its highest-ever temperature of 42.5C
-
Sri Lanka deploys troops after prison riot
-
Trump says US, Israel to hold off on Iran strikes
-
Baltics transform from Soviet stagnation to startup hubs
-
Messi returns as Inter Miami draw 2-2 against Columbus Crew
-
AI keeps consumer prices high in 'RAMaggedon' chip crunch
-
Five of Cuba's 15 provinces without power as grid fails again
-
Dressel, Walsh win 50m free titles at US Swimming Championships
-
Baltic startups take aim at deterring Russia on NATO's eastern flank
-
OPEC+ tipped to raise production again but new quotas loom
-
Tourists chase high-octane thrill in China's trending biker capital
-
De Zerbi unsure over Richarlison's future at Spurs
-
Vincent Pastore, who played 'Big Pussy' on 'The Sopranos,' dead at 80
-
Tottenham manager De Zerbi 'happy' with pre-season progress
California start-up sends tiny robots on voyage into brains
Sending miniature robots deep inside the human skull to treat brain disorders has long been the stuff of science fiction -- but it could soon become reality, according to a California start-up.
Bionaut Labs plans its first clinical trials on humans in just two years for its tiny injectable robots, which can be carefully guided through the brain using magnets.
"The idea of the micro robot came about way before I was born," said co-founder and CEO Michael Shpigelmacher.
"One of the most famous examples is a book by Isaac Asimov and a film called 'Fantastic Voyage,' where a crew of scientists goes inside a miniaturized spaceship into the brain, to treat a blood clot."
Just as cellphones now contain extremely powerful components that are smaller than a grain of rice, the tech behind micro-robots "that used to be science fiction in the 1950s and 60s" is now "science fact," said Shpigelmacher.
"We want to take that old idea and turn it into reality," the 53-year-old scientist told AFP during a tour of his company's Los Angeles research and development center.
Working with Germany's prestigious Max Planck research institutes, Bionaut Labs settled on using magnetic energy to propel the robots -- rather than optical or ultrasonic techniques -- because it does not harm the human body.
Magnetic coils placed outside the patient's skull are linked up to a computer that can remotely and delicately maneuver the micro-robot into the affected part of the brain, before removing it via the same route.
The entire apparatus is easily transportable, unlike an MRI, and uses 10 to 100 times less electricity.
- 'You're stuck' -
In a simulation watched by AFP, the robot -- a metal cylinder just a few millimeters long, in the shape of a tiny bullet -- slowly follows a pre-programed trajectory through a gel-filled container, which emulates the density of the human brain.
Once it nears a pouch filled with blue liquid, the robot is swiftly propelled like a rocket and pierces the sack with its pointed end, allowing liquid to flow out.
Inventors hope to use the robot to pierce fluid-filled cysts within the brain when clinical trials begin in two years.
If successful, the process could be used to treat Dandy-Walker Syndrome, a rare brain malformation affecting children.
Sufferers of the congenital ailment can experience cysts the size of a golf ball, which swell and increase pressure on the brain, triggering a host of dangerous neurological conditions.
Bionaut Labs has already tested its robots on large animals such as sheep and pigs, and "the data shows that the technology is safe for us" human beings, said Shpigelmacher.
If approved, the robots could offer key advantages over existing treatments for brain disorders.
"Today, most brain surgery and brain intervention is limited to straight lines -- if you don't have a straight line to the target, you're stuck, you're not going to get there," said Shpigelmacher.
Micro-robotic tech "allows you to reach targets you were not able to reach, and reaching them repeatedly in the safest trajectory possible," he added.
- 'Heating up' -
The US Food and Drug Administration (FDA) last year granted Bionaut Labs approvals that pave the way for clinical trials to treat Dandy-Walker Syndrome, as well as malignant gliomas -- cancerous brain tumors often considered to be inoperable.
In the latter case, the micro-robots will be used to inject anti-cancer drugs directly into brain tumors in a "surgical strike."
Existing treatment methods involve bombarding the whole body with drugs, leading to potential severe side effects and loss of effectiveness, said Shpigelmacher.
The micro-robots can also take measurements and collect tissue samples while inside the brain.
Bionaut Labs -- which has around 30 employees -- has held discussions with partners for the use of its tech to treat other conditions affecting the brain including Parkinson's, epilepsy or strokes.
"To the best of my knowledge, we are the first commercial effort" to design a product of this type with "a clear path to the clinic trials," said Shpigelmacher.
"But I don't think that we will be the only one... This area is heating up."
O.Lorenz--BTB